The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Open accessAbstract
Introduction: Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD) neuropathology and dementia early in life. Blood biomarkers of AD neuropathology would be valuable, as non‐AD intellectual disabilities of DS and AD dementia overlap clinically. We hypothesized that elevations of amyloid β (Aβ) peptides and phosphorylated‐tau in neuronal exosomes may document preclinical AD. Methods: AD neuropathogenic proteins Aβ 1–42, P‐T181‐tau, and P‐S396‐tau were quantified by enzyme‐linked immunosorbent assays in extracts of neuronal exosomes purified from blood of individuals with DS and age‐matched controls. Results: Neuronal exosome levels of Aβ 1–42, P‐T181‐tau, and P‐S396‐tau were significantly elevated in individuals with DS compared with age‐matched controls at all ages beginning in childhood. No significant gender differences were observed. Discussion: These early increases in Aβ 1–42, P‐T181‐tau, and P‐S396‐tau in individuals with DS may provide a basis for early intervention as targeted treatments become available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The rationale for using plasma biomarkers as proxies for brain processes [173] has been demonstrated for multiple neurodegenerative diseases [174, 175].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159
Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., Abner, E. L., Petersen, R. C., Federoff, H. J., Miller, B. L., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.008 · Cited by 959
Self-citationHaass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584 · cited 1×
“Amyloid pathology has been observed as early as 15 years of age in postmortem brain samples from individuals with DS [4].”
BackgroundA genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3983 · Cited by 562
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
Jaunmuktane, Z., Mead, S., Ellis, M., Wadsworth, J. D. F., Nicoll, A. J., Kenny, J., Launchbury, F., Linehan, J., Richard-Loendt, A., Walker, A. S., et al. (2015) · Nature · doi:10.1038/nature15369 · Cited by 518
Mann, D. M. A., & Esiri, M. M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90019-1 · Cited by 471
Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease
Goetzl, E. J., Boxer, A., Schwartz, J. B., Abner, E. L., Petersen, R. C., Miller, B. L., & Kapogiannis, D. (2015) · Neurology · doi:10.1212/wnl.0000000000001702 · Cited by 446
Self-citationLongitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease
Fagan, A. M., Xiong, C., Jasielec, M. S., Bateman, R. J., Goate, A. M., Benzinger, T. L. S., Ghetti, B., Martins, R. N., Masters, C. L., Mayeux, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007901 · Cited by 434
Cited by
Sorted by citations
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1868-1 · Cited by 527
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., & Karamanos, Y. (2020) · Cells · doi:10.3390/cells9040851 · Cited by 503
Mustapic, M., Eitan, E., Werner, J. K., Berkowitz, S. T., Lazaropoulos, M. P., Tran, J., Goetzl, E. J., & Kapogiannis, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00278 · Cited by 441
Self-citationDementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383
Self-citationAlzheimer's disease associated with Down syndrome: a genetic form of dementia
Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00245-3 · Cited by 357
Self-citationLewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramírez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 318
Mechanisms of secretion and spreading of pathological tau protein
Brunello, C. A., Merezhko, M., Uronen, R.-L., & Huttunen, H. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03349-1 · Cited by 304
L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma
Norman, M., Ter‐Ovanesyan, D., Trieu, W., Lazarovits, R., Kowal, E. J. K., Lee, J.-H., Chen‐Plotkin, A. S., Regev, A., Church, G. M., & Walt, D. R. (2021) · Nature Methods · doi:10.1038/s41592-021-01174-8 · Cited by 261
Pulliam, L., Sun, B., Mustapić, M., Chawla, S., & Kapogiannis, D. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0695-4 · Cited by 246
Kapogiannis, D., Mustapic, M., Shardell, M. D., Berkowitz, S. T., Diehl, T. C., Spangler, R. D., Tran, J., Lazaropoulos, M. P., Chawla, S., Gulyani, S., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2462 · Cited by 241
Self-citationDetection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles
Guix, F. X., Corbett, G. T., Cha, D., Mustapić, M., Liu, W., Mengel, D., Chen, Z., Aïkawa, E., Young‐Pearse, T. L., Kapogiannis, D., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030663 · Cited by 186
New windows into the brain: Central nervous system-derived extracellular vesicles in blood
Shi, M., Sheng, L., Stewart, T., Zabetian, C. P., & Zhang, J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.005 · Cited by 181
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease
Martins, T. S., Trindade, D., Vaz, M., Campelo, I., Almeida, M., Trigo, G., Silva, O. A. B. D. C. E., & Henriques, A. G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15112 · Cited by 177
McKeever, P. M., Schneider, R., Taghdiri, F., Weichert, A., Multani, N., Brown, R. A., Boxer, A. L., Karydas, A., Miller, B., Robertson, J., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1032-x · Cited by 166
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment
Hosseini, N. F., Sheykhhasan, M., Asl, S. S., & Najafi, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02324-x · Cited by 155
Gauthier, S. A., Pérez‐González, R., Sharma, A., Huang, F.-K., Alldred, M. J., Pawlik, M., Kaur, G., Ginsberg, S. D., Neubert, T. A., & Levy, E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0466-0 · Cited by 125
Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV
Sun, B., Dalvi, P., Abadjian, L. R., Tang, N., & Pulliam, L. (2017) · AIDS · doi:10.1097/qad.0000000000001595 · Cited by 123
Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
Rayaprolu, S., Higginbotham, L., Bagchi, P., Watson, C. M., Zhang, T., Levey, A. I., Rangaraju, S., & Seyfried, N. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00840-3 · Cited by 118
Winston, C. N., Romero, H. K., Ellisman, M., Nauss, S., Julovich, D. A., Conger, T., Hall, J. R., Campana, W., O’Bryant, S. E., Nievergelt, C. M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01005 · Cited by 105
Alzheimer's disease in Down syndrome: an overlooked population for prevention trials
Strydom, A., Coppus, A., Blesa, R., Danek, A., Fortea, J., Hardy, J., Levin, J., Nuebling, G., Rebillat, A., Ritchie, C., et al. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.10.006 · Cited by 110
Self-citationBrain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yü, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 103
Further understanding the connection between Alzheimer's disease and Down syndrome
Snyder, H. M., Bain, L. J., Brickman, A. M., Carrillo, M. C., Esbensen, A. J., Espinosa, J. M., Fernandez, F., Fortea, J., Hartley, S. L., Head, E., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12112 · Cited by 105
Self-citationOpportunities, barriers, and recommendations in Down syndrome research
Hendrix, J. A., Amon, A., Abbeduto, L., Agiovlasitis, S., Alsaied, T., Anderson, H. A., Bain, L. J., Baumer, N., Bhattacharyya, A., Bogunovic, D., et al. (2021) · Translational Science of Rare Diseases · doi:10.3233/trd-200090 · Cited by 117
Self-citationEffects of exercise on exosome release and cargo in in vivo and ex vivo models: A systematic review
Estébanez, B., Jiménez‐Pavón, D., Huang, C., Cuevas, M. J., & González‐Gallego, J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30094 · Cited by 94
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
Startin, C. M., Ashton, N. J., Hamburg, S., Hithersay, R., Wiseman, F. K., Mok, K. Y., Hardy, J., Lleó, A., Lovestone, S., Parnetti, L., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0477-0 · Cited by 86
Soliman, H. M., Ghonaim, G. A., Gharib, S. M., Chopra, H., Farag, A. K., Hassanin, M. H., Nagah, A., Emad-Eldin, M., Hashem, N. E., Yahya, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910794 · Cited by 81
Eren, E., Hunt, J. F. V., Shardell, M. D., Chawla, S., Tran, J., Gu, J., Vogt, N. M., Johnson, S. C., Bendlin, B. B., & Kapogiannis, D. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12130 · Cited by 81
Exosomal biomarkers in Down syndrome and Alzheimer's disease
Hamlett, E. D., Ledreux, A., Potter, H., Chial, H. J., Patterson, D., Espinosa, J. M., Bettcher, B. M., & Granholm, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.028 · Cited by 80
Self-citationNeuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo
Winston, C. N., Aulston, B. D., Rockenstein, E. M., Adame, A., Prikhodko, O., Dave, K. N., Mishra, P., Rissman, R. A., & Yuan, S. H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180776 · Cited by 77
Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
Watson, L. S., Hamlett, E. D., Stone, T. D., & Sims‐Robinson, C. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0317-5 · Cited by 75
Self-citationBrain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104772 · Cited by 73
Genetic and Pharmacological Discovery for Alzheimer’s Disease Using Caenorhabditis elegans
Griffin, E. F., Caldwell, K. A., & Caldwell, G. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00361 · Cited by 70
A cell-based assay for CD63-containing extracellular vesicles
Cashikar, A. G., & Hanson, P. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220007 · Cited by 70
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Baldacci, F., Mazzucchi, S., Vecchia, A. D., Giampietri, L., Giannini, N., Koronyo‐Hamaoui, M., Ceravolo, R., Siciliano, G., Bonuccelli, U., Elahi, F. M., et al. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1731306 · Cited by 65
Tissue Engineering and Regenerative Medicine 2017: A Year in Review
Park, K. M., Shin, Y. M., Kim, K., & Shin, H. (2018) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2018.0027 · Cited by 61
Extracellular vesicles as an emerging tool for the early detection of Alzheimer’s disease
Li, T.-R., Wang, X.-N., Sheng, C., Li, Y.-X., Li, F. Z.-T., Sun, Y., & Han, Y. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111175 · Cited by 60
Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies
Rahman, M. A., Patters, B. J., Kodidela, S., & Kumar, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09848-z · Cited by 59
A Pilot Study of Urinary Exosomes in Alzheimer’s Disease
Sun, R., Wang, H., Shi, Y., Gao, D., Sun, Z., Chen, Z., Jiang, H., & Zhang, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505851 · Cited by 61
Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases
Butterfield, D. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179912 · Cited by 57
Winston, C. N., Goetzl, E. J., Baker, L. D., Vitiello, M. V., & Rissman, R. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180302 · Cited by 54
Self-citationGallart‐Palau, X., Serra, A., Hase, Y., Tan, C. F., Chen, C., Kalaria, R. N., & Sze, S. K. (2019) · Brain Pathology · doi:10.1111/bpa.12699 · Cited by 55
Perez, S. E., Miguel, J. C., He, B., Malek‐Ahmadi, M. H., Abrahamson, E. E., Ikonomović, M. D., Lott, I. T., Doran, E. W., Alldred, M. J., Ginsberg, S. D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01965-6 · Cited by 48
Self-citationTan, Y. J., Wong, B. Y. X., Vaidyanathan, R., Sreejith, S., Chia, S. Y., Kandiah, N., Ng, A. S. L., & Zeng, L. (2021) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210311 · Cited by 48
Increased levels of plasma total tau in adult Down syndrome
Kasai, T., Tatebe, H., Kondo, M., Ishii, R., Ohmichi, T., Yeung, W. T. E., Morimoto, M., Chiyonobu, T., Terada, N., Allsop, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188802 · Cited by 48
Recent advances in optical label‐free characterization of extracellular vesicles
Imanbekova, M., Suarasan, S., Lu, Y. P., Jurchuk, S., & Wachsmann‐Hogiu, S. (2022) · Nanophotonics · doi:10.1515/nanoph-2022-0057 · Cited by 47
Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
Montoliu‐Gaya, L., Strydom, A., Blennow, K., Zetterberg, H., & Ashton, N. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163639 · Cited by 46
Recent Advances on Extracellular Vesicles in Central Nervous System Diseases
Jin, T., Gu, J., Li, Z., Xu, Z., & Gui, Y. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s288415 · Cited by 44
Perrotte, M., Haddad, M., Page, A. Y. L., Frost, E. H., Fülöp, T., & Ramassamy, C. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.010 · Cited by 42
Sun, R., Wang, H., Shi, Y., Sun, Z., Jiang, H., & Zhang, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190497 · Cited by 42
Kandeel, M. K., Morsy, M. A., Alkhodair, K. M., & Alhojaily, S. (2023) · Biomolecules · doi:10.3390/biom13081250 · Cited by 40
Wang, H., Atik, A., Stewart, T., Ginghină, C., Aro, P., Kerr, K. F., Seibyl, J. P., Jennings, D. L., Jensen, P. H., MAREK, K. L., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.015 · Cited by 41
Extracellular Vesicles in CNS Developmental Disorders
Gomes, A. R., Sangani, N. B., Fernandes, T. G., Diogo, M. M., Curfs, L., & Reutelingsperger, C. P. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249428 · Cited by 41
Extracellular vesicles, new actors in the search for biomarkers of dementias
Gámez‐Valero, A., Beyer, K., & Borràs, F. E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.006 · Cited by 38
Perluigi, M., Picca, A., Montanari, E., Calvani, R., Marini, F., Matassa, R., Tramutola, A., Villani, A., Familiari, G., Domenico, F. D., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12499 · Cited by 35
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Granholm, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093190 · Cited by 37
Self-citationExtracellular vesicles and pancreatitis: mechanisms, status and perspectives
Jia, Y., Ding, Y., Mei, W., Wang, Y., Zheng, Z. G., Qu, Y., Liang, K., Li, J. X., Cao, F., & Li, F. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.54858 · Cited by 34
Exosomes as drug delivery vehicles and biomarkers for neurological and auditory systems
Mittal, R., Bencie, N., Langlie, J. A., Mittal, J., & Eshraghi, A. A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30484 · Cited by 36
Griffin, E. F., Yan, X., Caldwell, K. A., & Caldwell, G. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy308 · Cited by 34
Zhang, G., Li, L., Kong, Y., Xu, D., Bao, Y., Zhang, Z., Liao, Z., Jiao, J., Fan, D., Long, X., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.049 · Cited by 30
Pineles, B. L., Mani, A., Sura, L., Rossignol, C., Albayram, S., Weiss, M. D., & Goetzl, L. M. (2021) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2020-321096 · Cited by 28
Extracellular vesicles in mammalian reproduction: a review
Muñoz, E., Fuentes, F., Felmer, R. N., Yeste, M., & Arias, M. E. (2022) · Zygote · doi:10.1017/s0967199422000090 · Cited by 30
Toward Exosome-Based Neuronal Diagnostic Devices
Yoo, Y. K., Lee, J., Kim, H., Hwang, K., Yoon, D., & Lee, J. H. (2018) · Micromachines · doi:10.3390/mi9120634 · Cited by 27
Blood‐based biomarkers for Down syndrome and Alzheimer's disease: A systematic review
Petersen, M. E., & O’Bryant, S. E. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22714 · Cited by 27
Plasma amyloid and tau as dementia biomarkers in Down syndrome: Systematic review and meta‐analyses
Alhajraf, F., Ness, D., Hye, A., & Strydom, A. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22715 · Cited by 25
Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
Lemoine, L., Ledreux, A., Mufson, E. J., Perez, S. E., Šimić, G., Doran, E. W., Lott, I. T., Carroll, S. L., Bharani, K., Thomas, S., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00414-3 · Cited by 29
Self-citationSalvi, A., Vezzoli, M., Busatto, S., Paolini, L., Faranda, T., Abeni, E., Caracausi, M., Antonaros, F., Piovesan, A., Locatelli, C., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4158 · Cited by 25
Circulating Exosomes of Neuronal Origin as Potential Early Biomarkers for Development of Stroke
Yousif, G., Qadri, S. M., Haik, M. Y., Haik, Y., Parray, A., & Shuaib, A. M. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00508-0 · Cited by 27
Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome
Botté, A., & Potier, M. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.002 · Cited by 22
Petersen, M. E., Zhang, F., Schupf, N., Krinsky‐McHale, S. J., Hall, J. R., Mapstone, M. E., Cheema, A. K., Silverman, W. P., Lott, I. T., Rafii, M. S., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12039 · Cited by 22
Self-citationBiogenesis, Biologic Function and Clinical Potential of Exosomes in Different Diseases
Beshbishy, A. M., Alghamdi, S. A., Onyiche, T. E., Zahoor, M., Rivero-Pérez, N., Zaragoza-Bastida, A., Ghorab, M. A., Meshaal, A. K., El-Esawi, M. A., Hetta, . F., et al. (2020) · Applied Sciences · doi:10.3390/app10134428 · Cited by 22
A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
Lee, N., Chien, Y., & Hwu, W. (2017) · Neurology and Therapy · doi:10.1007/s40120-017-0071-y · Cited by 23
Ledreux, A., Thomas, S., Hamlett, E. D., Trautman, C. W., Gilmore, A., Hager, E. R., Paredes, D., Margittai, M., Fortea, J., & Granholm, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173931 · Cited by 23
Self-citationHan, X., Zhou, L., Tu, Y., Wei, J., Zhang, J., Jiang, G., Shi, Q., & Ying, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.881175 · Cited by 22
Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 24
Neuron-derived extracellular vesicle-based diagnostics for Tau and Alzheimer’s disease
Chinnathambi, S., Kumarappan, M., Malik, S., Velmurugan, G., & Chandrashekar, M. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2024.12.006 · Cited by 21
Exosome release and cargo in Down syndrome
Hamlett, E. D., LaRosa, A., Mufson, E. J., Fortea, J., Ledreux, A., & Granholm, A. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22712 · Cited by 21
Self-citationAbdel–Haq, H. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00493-4 · Cited by 22
Inflammatory biomarkers and intellectual disability in patients with Down syndrome
Manti, S., Cutrupi, M. C., Cuppari, C., Ferro, E., Dipasquale, V., Rosa, G. D., Chimenz, R., Rosa, M. A. L., Valenti, A., & Salpietro, V. (2018) · Journal of Intellectual Disability Research · doi:10.1111/jir.12470 · Cited by 20
Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
Andrews, E. J., Martini, A. C., & Head, E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.954999 · Cited by 21
Neural-Derived Extracellular Vesicles in Clinical Trials
Dubal, D. B., & Pleasure, S. J. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4325 · Cited by 20
Clinical implications of extracellular vesicles in neurodegenerative diseases
Vinaiphat, A., & Sze, S. K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1657407 · Cited by 20
Down syndrome biobank consortium: a perspective
Aldecoa, I., Barroeta, I., Carroll, S. L., Fortea, J., Gilmore, A., Ginsberg, S. D., Guzman, S. J., Hamlett, E. D., Head, E., Perez, S. E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13692 · Cited by 19
Self-citationThe Role of Tau Pathology in Alzheimer’s Disease and Down Syndrome
Granholm, A., & Hamlett, E. D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051338 · Cited by 23
Self-citationSearching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.004 · Cited by 18
Dayarathna, T. K., Roseborough, A. D., Gomes, J., Khazaee, R., Silveira, C. R. A., Borron, K., Yu, S., Coleman, K. K. L., Jesso, S., Finger, E. C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14087 · Cited by 19
Li, X., Chen, J., Yang, Y., Cai, H., Ao, Z., Xing, Y., Li, K., Yang, K., Guan, W., Friend, J., et al. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00916-4 · Cited by 17
Videla, L., Benejam, B., Barroeta, I., Fernández, S., Altuna, M., Arranz, J., Rodríguez‐Baz, Í., Arriola‐Infante, J. E., Maure‐Blesa, L., Soriano, L. D. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70259 · Cited by 17
Self-citationEnrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
Valle‐Tamayo, N., Pérez‐González, R., Chiva‐Blanch, G., Belbin, O., Serrano‐Requena, S., Sirisi, S., González, A. C., Giró, O., Sánchez‐Aced, É., Dols‐Icardo, O., et al. (2022) · Journal of Visualized Experiments · doi:10.3791/64107 · Cited by 19
Self-citationShen, H., Chen, J., Liu, M., Zhao, M., Hu, D., Xie, F., Jin, Q., Xiao, D., Peng, Z., Qin, T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1496304 · Cited by 17
Sukreet, S., Rafii, M. S., & Rissman, R. A. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12580 · Cited by 13
Proteomics for comprehensive characterization of extracellular vesicles in neurodegenerative disease
Vinaiphat, A., & Sze, S. K. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114149 · Cited by 14
Vesicular trafficking and cell-cell communication in neurodevelopment and neurodegeneration
Amin, S., & Taverna, E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1600034 · Cited by 14
Roles of Bile‐Derived Exosomes in Hepatobiliary Disease
Yao, Y., Dechao, J., Li, Z., Zhou, X., Li, J., Liu, Z., & Han, X. (2021) · BioMed Research International · doi:10.1155/2021/8743409 · Cited by 14
Хаспеков, Л. Г., & Yakovlev, A. A. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010087 · Cited by 12
Dierssen, M., Hérault, Y., Helguera, P. R., de Lagrán, M. M., Vázquez, A. V., Christian, B. T., Carmona‐Iragui, M., Wiseman, F. K., Mobley, W. C., Fisher, E., et al. (2021) · Molecular Syndromology · doi:10.1159/000514437 · Cited by 11
Self-citationMoussaed, M., Huc-Brandt, S., Cubedo, N., Silhol, M., Murat, S., Lebart, M., Kovács, G. G., Verdier, J., Trousse, F., Rossel, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.029 · Cited by 11
Exosomes: new targets for understanding axon guidance in the developing central nervous system
Liu, M., & Teng, T. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1510862 · Cited by 10
Zhou, Y., Sheehan, R., Guo, L., & Strydom, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70135 · Cited by 10
Down syndrome and dementia: advances in the field
McGlinchey, E., McCallion, P., & McCarron, M. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000589 · Cited by 9
Alpha‐synuclein co‐pathology in Down syndrome‐associated Alzheimer's disease
Bernhardt, A. M., Rodríguez‐Baz, Í., Aldecoa, I., Arranz, J., Arriola‐Infante, J. E., Maure‐Blesa, L., Carmona‐Iragui, M., Longen, S., Trossbach, S. V., Giese, A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70342 · Cited by 7
Self-citation
Metadata
- Authors
- Hamlett, E. D., Goetzl, E. J., Ledreux, A., Vasilevko, V., Boger, H. A., LaRosa, A., Clark, D., Carroll, S. L., Carmona‐Iragui, M., Fortea, J., Mufson, E. J., Sabbagh, M., Mohammed, A. H., Hartley, D., Doran, E., Lott, I. T., & Granholm, A.
- Affiliations
- University of Denver (US)
- University of California, San Francisco (US)
- University of California, Irvine (US)
- Medical University of South Carolina (US)
- Hospital de Sant Pau (ES)
- Barrow Neurological Institute (US)
- Linnaeus University (SE)
- Alzheimer's Association (US)
- Corresponding author
- Granholm, Ann‐Charlotte
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-10-15
- Volume
- 13
- Issue
- 5
- Pages
- 541-549
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC5812672
- OpenAlex
- W2537024319
- Cited by
- 129
- References
- 47
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 19 · 2020: 17 · 2019: 25 · 2018: 15 · 2017: 9
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons - DU (University of Denver) (submittedVersion)
- Funders
- National Institutes of Health (R01AG 21912, R01HD065160, RO1AG04375, PO1AG14449)
- National Center for Research Resources
- National Center for Advancing Translational Sciences (UL1 TR000153)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Down syndrome, Alzheimer's disease
- MeSH terms
- Adolescent, Alzheimer Disease, Down Syndrome, Female, Humans, Male, Middle Aged, Peptide Fragments, Biomarkers, Amyloid beta-Peptides, tau Proteins, Exosomes, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
